Fiche société
German University in Cairo
Traitements, essais et publications liés.
Traitements2programmes
Essais1liés
Publications2liées
SourceDBlocale
Traitements
2| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| MetFORMIN 1000 Mg Oral TabletThis study aims to evaluate the effect of Metformin as add- on therapy for improving the outcome in RRMS patients. | SEP | Phase 2 | À vérifier | Egypt | À vérifier |
| MetFORMIN 1000 Mg Oral TabletThis study aims to evaluate the effect of Metformin as add- on therapy for improving the outcome in RRMS patients. | SEP | Phase 2 | À vérifier | Egypt | À vérifier |
Essais cliniques
1| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| MetFORMIN 1000 Mg Oral Tablet | SEP | Phase 2 | NCT05298670 | Drug Repurposing Using Metformin for Improving the Therapeutic Outcome in Multiple Sclerosis Patients | UNKNOWN |
Publications
2| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| MetFORMIN 1000 Mg Oral Tablet | A multimodal precision-prevention approach combining lifestyle intervention with metformin repurposing to prevent cognitive impairment and disability: the MET-FINGER randomised controlled trial protocol. | Alzheimer's research & therapy | ||
| MetFORMIN 1000 Mg Oral Tablet | Pharmacokinetic comparison between fixed-dose combination and loose combination of enavogliflozin 0.3 mg and metformin HCl 1000 mg in healthy subjects under fasting and fed conditions. | Naunyn-Schmiedeberg's archives of pharmacology |